This course has expired. View available courses.

Endocrinology, Oncology

Closing the Knowledge Gap: RAI-Refractory Differentiated Thyroid Cancer

Differentiated thyroid cancer (DTC) is the most common type of thyroid cancer. Of those patients diagnosed with DTC, approximately 5 to 15% may be RAI-Refractory. There is currently no consensus that defines RAI-refractory differentiated thyroid cancer (RAIR-DTC) or offers clinical scenarios that are an absolute indicator of the condition. To address this topic, this program consists of short educational videos on Differentiated thyroid cancer and the treatment of RAI-Refractory patients. Dr. Stan VanUum and Dr. Dean Ruether will discuss common issues healthcare professionals, including endocrinologists and oncologists, may have concerning the challenges of identifying and treating RAIR-DTC patients.

DURATION

30 mins

PROFESSION

Physician, Specialist

# OF CREDITS

0.5

ACCREDITATION

MOC - Section 3

EXPIRY DATE

2021-02-14

Differentiated thyroid cancer (DTC) is the most common type of thyroid cancer. Of those patients diagnosed with DTC, approximately 5 to 15% may be RAI-Refractory. There is currently no consensus that defines RAI-refractory differentiated thyroid cancer (RAIR-DTC) or offers clinical scenarios that are an absolute indicator of the condition. To address this topic, this program consists of short educational videos on Differentiated thyroid cancer and the treatment of RAI-Refractory patients. Dr. Stan VanUum and Dr. Dean Ruether will discuss common issues healthcare professionals, including endocrinologists and oncologists, may have concerning the challenges of identifying and treating RAIR-DTC patients.

Faculty

Dr. Andree Boucher, MD, FRCPC

Dr. Murali Rajamaran, MD, FRCPC

Dr. Stan VanUum, MD, PhD, FRCPC

Dr. Dean Ruether, MD, FRCPC


Learning objectives

Upon completion of this program, the participants will be able to:

  • Identify differentiated thyroid cancer patients likely to be RAI-Refractory (RAIR-DTC)
  • Initiate treatment with a tyrosine kinase inhibitor (TKI) in RAI-Refractory Differentiated Thyroid Cancer (RAIR-DTC) patients
  • Manage adverse events associated with TKIs, including prevention and early detection
  • Address the challenges of patient expectations

Accreditation

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada, and approved by the Canadian Society of Endocrinology and Metabolism. Remember to visit MAINPORT to record your learning and outcomes. You may claim a maximum of 0.5 hours (credits are automatically calculated). Accreditation ID: 00011681.
Cost of course:  
Free
# of credits: 0.5
Duration: 30 mins

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the ‚ÄúMain‚ÄĚ page and/or ‚ÄúAccreditation‚ÄĚ page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the ‚ÄúAccreditation‚ÄĚ or ‚ÄúCME Information‚ÄĚ pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the ‚ÄúMain‚ÄĚ page and/or ‚ÄúAccreditation‚ÄĚ page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the ‚ÄúAccreditation‚ÄĚ or ‚ÄúCME Information‚ÄĚ pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit¬†My Profile. If you would like to update the information here don‚Äôt forget to hit the ‚Äėsave‚Äô button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.